Researchers examined trial documents from 78 randomized trials conducted between 1991 and 2011 for 17 antibiotics. These documents included study protocols, statistical analysis plans and informed consent forms submitted to the European Medicines Agency. The trials included 39,407 patients. The research team analyzed documents from 50 trails in the informed consent form analysis.
All informed consent forms contained sections describing study purpose. But, none consistently conveyed the hypothesis to both methodologists and patient investigators. Methodologists found one in 50 conveyed a study purpose, while patient investigators found 11 of 50 did the same.
“Patients were not accurately informed of study purpose, which raises questions regarding the ethics of informed consent in antibiotic trials,” study authors concluded.
More articles on healthcare quality:
Study: Antimicrobial nursing scrubs ineffective at limiting bacterial contamination
37 sickened in multistate Salmonella outbreak linked to pet turtles
APIC: 6 tips for infection prevention after a hurricane
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.